Xiaodan Mao

18PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersComputational physiologyChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 18, 2026
Circulating Sex Hormone Levels and Survival in Men With Esophageal Squamous Cell Carcinoma.

|Jul 10, 2026
Integrating epigenetic and metabolic indicators for non-invasive endometrial cancer triage: a machine learning approach.

|Jun 17, 2026
Metabolic activation of LDHA by ERRα represses inflammasome-dependent pyroptosis and promotes ovarian cancer chemoresistance.

|Dec 24, 2025
Targeting the CD47-HCK-LGALS9 axis disrupts proliferation-immunosuppression coupling in early-stage endometrial cancer.

Jingxuan Ye, Yitong Yan, Xiaoqi Sun

|Dec 04, 2025
Differential Mediating Roles of Immune-Inflammatory Cells in ≥HSIL Women: A Focus on HPV and CD4/CD8 or NLR.

Yao Tong, Yuqin Gao, Xuanhao Wu

|Sep 29, 2025
Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer.

Jincheng Ma, Xiaodan Mao, Yuan Ren

Pageof 3

Frequent Collaborators

15 joint publications

Pengming Sun

5 joint publications

Binhua Dong

5 joint publications

HuiFang Lei

4 joint publications

Guanyu Ruan